# GlycoNex Announces Japanese Regulatory Submission for Denosumab Biosimilar SPD8

- Source: PR Newswire M&A
- Published: 2026-11-09T01:02:00+00:00
- Category: Business
- Original: https://www.prnewswire.com/news-releases/glyconex-announces-japanese-regulatory-submission-for-denosumab-biosimilar-spd8-302930180.html
- Canonical: https://groundlevelnews.com/story/glyconex-announces-japanese-regulatory-submission-for-denosumab-biosim-62ae8b/

Regulatory decision in Japan anticipated as early as the end of 2027, subject to PMDA review; GlycoNex continues to seek partners for markets outside Japan NEW TAIPEI CITY, Nov. 8, 2026 /PRNewswire/ -- GlycoNex, Inc. (TPEx: 4168), a clinical-stage biotechnology company developing...

_Ground Level News shows a short summary only; the full article and all rights belong to PR Newswire M&A._